✦ LIBER ✦

373 Lack of pharmacokinetic interaction between erlotinib, docetaxel and capecitabine in breast cancer patients

✍ Scribed by A. Rakhit; S. Fettner; S. Davis; R. Abbas; F. De Rosa; U. Brennschneidt; C. Twelves; J. Baselga

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Erlotinib in combination with capecitabi

✍ Chris Twelves; José M. Trigo; Rob Jones; Flavio De Rosa; Ashok Rakhit; Scott Fet 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 190 KB

Pharmacokinetic (PK) interaction between

✍ Cattel, L.; Airoldi, M.; Brusa, P.; Tagini, V.; Recalenda, V.; Marchionatti, S.; 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 143 KB

Interaction between capecitabine and bri

✍ Baena-Cañada, José M.; Martínez, María J.; García-Olmedo, Obdulia; Jiménez-Bárce 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 305 KB

Pharmacokinetics of capecitabine (Xeloda

✍ Bruno Reigner; Toru Watanabe; Johannes Schüller; Helen Lucraft; Yasutsuna Sasaki 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 243 KB

Phase II Study of Weekly Docetaxel and C

✍ Ewa Mrozek; Bhuvaneswari Ramaswamy; Donn Young; Chris A. Rhoades; Kari Kendra; J 📂 Article 📅 2006 🏛 CIG Media Group, LP. 🌐 English ⚖ 111 KB

Lack of pharmacokinetic interaction betw

✍ J.P. Leach; J. Girvan; V. Jamieson; T. Jones; A. Richens; M.J. Brodie 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 563 KB